Estimating The Fair Value Of Tractor Supply Company (NASDAQ:TSCO)
Using the 2 Stage Free Cash Flow to Equity, Tractor Supply fair value estimate is US$49.55
With US$57.63 share price, Tractor Supply appears to be trading close to its estimated fair value
The US$62.41 analyst price target for TSCO is 26% more than our estimate of fair value
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Tractor Supply Company (NASDAQ:TSCO) as an investment opportunity by taking the expected future cash flows and discounting them to today's value. This will be done using the Discounted Cash Flow (DCF) model. It may sound complicated, but actually it is quite simple!
We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model.
This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.
Crunching The Numbers
We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we need to discount the sum of these future cash flows to arrive at a present value estimate:
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
Levered FCF ($, Millions)
US$972.5m
US$1.16b
US$1.29b
US$1.39b
US$1.49b
US$1.57b
US$1.65b
US$1.72b
US$1.79b
US$1.85b
Growth Rate Estimate Source
Analyst x6
Analyst x3
Est @ 10.88%
Est @ 8.50%
Est @ 6.83%
Est @ 5.66%
Est @ 4.85%
Est @ 4.27%
Est @ 3.87%
Est @ 3.59%
Present Value ($, Millions) Discounted @ 8.1%
US$899
US$991
US$1.0k
US$1.0k
US$1.0k
US$984
US$954
US$920
US$884
US$846
("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = US$9.5b
After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.9%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 8.1%.
Terminal Value (TV)= FCF2035 × (1 + g) ÷ (r – g) = US$1.9b× (1 + 2.9%) ÷ (8.1%– 2.9%) = US$37b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$37b÷ ( 1 + 8.1%)10= US$17b
The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is US$26b. The last step is to then divide the equity value by the number of shares outstanding. Relative to the current share price of US$57.6, the company appears around fair value at the time of writing. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.
Important Assumptions
We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Tractor Supply as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.1%, which is based on a levered beta of 1.201. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
See our latest analysis for Tractor Supply
SWOT Analysis for Tractor Supply
Strength
Debt is well covered by earnings and cashflows.
Dividends are covered by earnings and cash flows.
Weakness
Earnings declined over the past year.
Dividend is low compared to the top 25% of dividend payers in the Specialty Retail market.
Expensive based on P/E ratio and estimated fair value.
Opportunity
Annual earnings are forecast to grow for the next 3 years.
Threat
Annual earnings are forecast to grow slower than the American market.
Next Steps:
Although the valuation of a company is important, it shouldn't be the only metric you look at when researching a company. DCF models are not the be-all and end-all of investment valuation. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. For Tractor Supply, we've put together three further items you should look at:
Risks: We feel that you should assess the 1 warning sign for Tractor Supply we've flagged before making an investment in the company.
Management:Have insiders been ramping up their shares to take advantage of the market's sentiment for TSCO's future outlook? Check out our management and board analysis with insights on CEO compensation and governance factors.
Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the NASDAQGS every day. If you want to find the calculation for other stocks just search here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Fehler beim Abrufen der Daten
Melden Sie sich an, um Ihr Portfolio aufzurufen.
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten
Fehler beim Abrufen der Daten

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Carry Wealth Holdings Leads The Charge In Asian Penny Stocks
Amidst a backdrop of global economic uncertainty, Asian markets have been navigating the complexities of trade tensions and fluctuating economic data. In such times, investors often look beyond established giants to explore opportunities in smaller or newer companies, sometimes referred to as penny stocks. Although the term may seem outdated, these stocks can still present valuable opportunities when backed by strong financials and growth potential. This article explores three Asian penny stocks that stand out for their balance sheet resilience and potential for significant returns. Top 10 Penny Stocks In Asia Name Share Price Market Cap Financial Health Rating Food Moments (SET:FM) THB4.10 THB4.05B ★★★★★☆ Lever Style (SEHK:1346) HK$1.48 HK$933.81M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.39 HK$1.99B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.515 SGD208.72M ★★★★★☆ T.A.C. Consumer (SET:TACC) THB4.66 THB2.8B ★★★★★★ China Sunsine Chemical Holdings (SGX:QES) SGD0.73 SGD695.97M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.53 SGD9.96B ★★★★★☆ Livestock Improvement (NZSE:LIC) NZ$1.00 NZ$142.34M ★★★★★★ Rojana Industrial Park (SET:ROJNA) THB4.70 THB9.5B ★★★★★★ BRC Asia (SGX:BEC) SGD3.57 SGD979.43M ★★★★★★ Click here to see the full list of 987 stocks from our Asian Penny Stocks screener. Let's review some notable picks from our screened stocks. Carry Wealth Holdings Simply Wall St Financial Health Rating: ★★★★★★ Overview: Carry Wealth Holdings Limited is an investment holding company that manufactures, trades, and markets garment products for various brands across the United States, Mainland China, Europe, Hong Kong, and internationally with a market cap of HK$431.93 million. Operations: The company's revenue is primarily derived from its Garment Manufacturing and Trading segment, which generated HK$664.69 million. Market Cap: HK$431.93M Carry Wealth Holdings Limited, with a market cap of HK$431.93 million, primarily generates revenue from its Garment Manufacturing and Trading segment. Despite being unprofitable, the company is debt-free and maintains a strong cash runway exceeding three years based on current free cash flow. Recent board changes introduced experienced financial professionals, potentially strengthening oversight. However, high share price volatility persists alongside negative return on equity at -22.85%. While short-term assets comfortably cover liabilities, both management and board tenures are relatively short, indicating an evolving leadership team as the company navigates its challenges in the competitive garment industry. Jump into the full analysis health report here for a deeper understanding of Carry Wealth Holdings. Review our historical performance report to gain insights into Carry Wealth Holdings' track record. Qinghai Spring Medicinal Resources Technology Simply Wall St Financial Health Rating: ★★★★★★ Overview: Qinghai Spring Medicinal Resources Technology Co., Ltd. operates in the medicinal resources sector and has a market cap of approximately CN¥25.01 billion. Operations: Qinghai Spring Medicinal Resources Technology Co., Ltd. has not reported specific revenue segments. Market Cap: CN¥2.5B Qinghai Spring Medicinal Resources Technology, with a market cap of CN¥25.01 billion, operates without significant revenue streams, indicating it may be pre-revenue. The company is debt-free and possesses a robust cash runway exceeding three years based on current free cash flow. Despite its unprofitability and negative return on equity at -15.54%, the management team and board are experienced, averaging tenures of 10.4 and 5.7 years respectively. Short-term assets significantly exceed liabilities, providing financial stability amidst challenges in achieving profitability as earnings have declined by 8.5% annually over the past five years. Navigate through the intricacies of Qinghai Spring Medicinal Resources Technology with our comprehensive balance sheet health report here. Learn about Qinghai Spring Medicinal Resources Technology's historical performance here. Zhejiang CONBA PharmaceuticalLtd Simply Wall St Financial Health Rating: ★★★★★★ Overview: Zhejiang CONBA Pharmaceutical Co., Ltd. focuses on the research, development, production, and sales of pharmaceuticals and health products in mainland China, with a market cap of CN¥11.53 billion. Operations: The company's revenue is primarily generated from its operations in China, amounting to CN¥6.38 billion. Market Cap: CN¥11.53B Zhejiang CONBA Pharmaceutical Co., Ltd. has shown financial resilience with a significant reduction in its debt to equity ratio from 63.8% to 3.9% over five years, and its short-term assets of CN¥4.5 billion comfortably cover both short and long-term liabilities. Despite a low return on equity at 8.7%, the company has maintained stable earnings growth, surpassing industry averages with a recent annual increase of 13.8%. However, its dividend track record remains unstable, and the board's average tenure of 1.6 years suggests limited experience in navigating market complexities effectively. Click here to discover the nuances of Zhejiang CONBA PharmaceuticalLtd with our detailed analytical financial health report. Assess Zhejiang CONBA PharmaceuticalLtd's previous results with our detailed historical performance reports. Make It Happen Explore the 987 names from our Asian Penny Stocks screener here. Curious About Other Options? Rare earth metals are the new gold rush. Find out which 25 stocks are leading the charge. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:643 SHSE:600381 and SHSE:600572. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@


Bloomberg
10 minutes ago
- Bloomberg
UBS Settles Credit Suisse Mortgage-Bond Case for $300 Million
UBS Group AG said it has reached an agreement with the US Department of Justice to resolve a legacy Credit Suisse matter related to the former bank's role in selling residential mortgage-backed securities in the US. 'On 1 August 2025, Credit Suisse Securities (USA) LLC entered into an agreement with the DOJ to resolve all of Credit Suisse's outstanding Consumer Relief Obligations under the 2017 settlement by paying $300 million,' the bank said in a statement on Monday.
Yahoo
23 minutes ago
- Yahoo
WeightWatchers (WW) Q1 Earnings: What To Expect
Personal wellness company WeightWatchers (NASDAQ:WW) will be reporting results this Tuesday before market open. Here's what investors should know. WeightWatchers beat analysts' revenue expectations by 6.5% last quarter, reporting revenues of $184.4 million, down 10.5% year on year. It was a strong quarter for the company, with a solid beat of analysts' EPS estimates. It reported 3.3 million members, up 6.5% year on year. Is WeightWatchers a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting WeightWatchers's revenue to decline 9.7% year on year to $180.3 million, improving from the 14.6% decrease it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.29 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. WeightWatchers has missed Wall Street's revenue estimates five times over the last two years. Looking at WeightWatchers's peers in the consumer discretionary segment, only American Outdoor Brands has reported results so far. It beat analysts' revenue estimates by 27.8%, delivering year-on-year sales growth of 33.8%. The stock was down 14.9% on the results. Read our full analysis of American Outdoor Brands's earnings results here. Investors in the consumer discretionary segment have had steady hands going into earnings, with share prices flat over the last month. WeightWatchers is up 5.4% during the same time. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.